Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_019112.3(ABCA7):c.2126_2132del (p.Glu709fs)	ABCA7	E709fs	not provided|Alzheimer disease, type 9|Primary degenerative dementia of the Alzheimer type, presenile onset	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000225544	19	1047508 - 1047514	19	1047509 - 1047515	225544	227447	rs547447016	NC_000019.10:1047508:GGAGCAGGG:GG
NM_022089.4(ATP13A2):c.2146del (p.Asp715_Leu716insTer)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001075284	1	17318334	1	16991839	1075284	1058472		NC_000001.11:16991838:GG:G
NM_022089.4(ATP13A2):c.1749+442_2251+512del	ATP13A2		Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000978042	1	17317717 - 17319682	1	16991222 - 16993187	978042	966155		
NM_022089.4(ATP13A2):c.409del (p.Val137fs)	ATP13A2	V137fs	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000859962	1	17331255	1	17004760	859962	822988		NC_000001.11:17004759:CC:C
NC_000001.11:g.(?_16991714)_(16992601_?)del	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000660676	1	17318209 - 17319096	1	16991714 - 16992601	660676	650536		
NM_022089.4(ATP13A2):c.3535del (p.Pro1178_Leu1179insTer)	ATP13A2	P1078fs	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000642673	1	17312724	1	16986229	642673	627059	rs1570752813	NC_000001.11:16986228:GGGGG:GGGG
NM_022089.4(ATP13A2):c.1777_1778del (p.Ala594fs)	ATP13A2	A589fs, A594fs	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000632090	1	17319048 - 17319049	1	16992553 - 16992554	632090	619966	rs1557683241	NC_000001.11:16992552:GAG:G
NM_022089.4(ATP13A2):c.2983del (p.Ala995fs)	ATP13A2	A951fs, A995fs, A990fs	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000632089	1	17313641	1	16987146	632089	619965	rs1414662479	NC_000001.11:16987145:CCCCC:CCCC
NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs)	ATP13A2	Y1020fs, Y976fs, Y1015fs	Kufor-Rakeb syndrome|not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000465253	1	17313567	1	16987072	465253	447466	rs765632065	NC_000001.11:16987071:G:
NM_022089.4(ATP13A2):c.348-9_351del	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2018)	criteria provided, conflicting interpretations	VCV000209135	1	17331313 - 17331325	1	17004818 - 17004830	209135	205723	rs749798211	NC_000001.11:17004817:CAGGCTGGGGAAGCAGG:CAGG
NM_022089.4(ATP13A2):c.2552_2553del (p.Phe851fs)	ATP13A2	F807fs, F846fs, F851fs	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000030834	1	17316242 - 17316243	1	16989747 - 16989748	30834	39791	rs587776890	NC_000001.11:16989746:AAA:A
ATP13A2, 1-BP DEL, 3057C	ATP13A2		Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001218					1218	16257		
NM_000077.5(CDKN2A):c.339_340delinsCT (p.Pro114Ser)	CDKN2A	P114S, A128L, P63S	Cutaneous malignant melanoma 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000009424	9	21971018 - 21971019	9	21971019 - 21971020	9424	24463	rs387906410	NC_000009.12:21971018:GC:AG
NC_000014.9:g.(31394019_31414809)_(31654321_31655889)del	DTD2|GPR33|HEATR5A|NUBPL		Parkinson disease, late-onset|Mitochondrial complex 1 deficiency, nuclear type 21	Pathogenic(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV000929501	14	31867179 - 32280475			929501	917820		
NM_012179.4(FBXO7):c.1183-4del	FBXO7		Parkinson disease 15|not provided	Likely benign(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000705190	22	32894127	22	32498140	705190	695874	rs1399849415	NC_000022.11:32498139:A:
NM_012179.4(FBXO7):c.1271_1272delinsAT (p.Phe424Tyr)	FBXO7	F310Y, F345Y, F424Y	Parkinson disease 15	Benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000704113	22	32894219 - 32894220	22	32498232 - 32498233	704113	694717	rs1601520476	NC_000022.11:32498231:TC:AT
NM_012179.4(FBXO7):c.1536_1539del (p.Arg513fs)	FBXO7	R399fs, R513fs, R434fs	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000640811	22	32894482 - 32894485	22	32498495 - 32498498	640811	649459	rs772175765	NC_000022.11:32498494:GGTCGG:GG
NM_012179.4(FBXO7):c.152del (p.Asn51fs)	FBXO7	N51fs	Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488517	22	32874996	22	32479009	488517	481385	rs1228608709	NC_000022.11:32479008:AA:A
NM_133372.3(FNIP1):c.2753_2756del (p.Lys918fs)	FNIP1	K873fs, K890fs, K918fs	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487638	5	131007381 - 131007384	5	131671688 - 131671691	487638	480688	rs1554092867	NC_000005.10:131671687:TCTTT:T
GRCh37/hg19 1q22(chr1:155188179-155209868)	GBA		Parkinson disease, late-onset	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000813310	1	155188179 - 155209868			813310	801562		
NM_001103146.3(GIGYF2):c.3630_3632del (p.Gln1216del)	GIGYF2	Q1216del, Q1237del, Q1210del	not provided|Parkinson disease 11	Benign(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV000518338	2	233712227 - 233712229	2	232847517 - 232847519	518338	508779	rs10555297	NC_000002.12:232847516:ACA:
NM_032620.4(GTPBP3):c.32_33delinsGTG (p.Gln11fs)	GTPBP3	Q11fs	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180619	19	17448452 - 17448453	19	17337643 - 17337644	180619	178785	rs886037736	NC_000019.10:17337642:AA:GTG
NM_002137.4(HNRNPA2B1):c.7-143del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001170361	7	26237495	7	26197875	1170361	1155684		NC_000007.14:26197874:AAAAAAAAAA:AAAAAAAAA
NM_002137.4(HNRNPA2B1):c.984_992del (p.329_331SGG[1])	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000541427	7	26232170 - 26232178	7	26192550 - 26192558	541427	522884	rs754021381	NC_000007.14:26192549:CCTCCACTGCCTCC:CCTCC
NM_198578.4(LRRK2):c.6584_6586del (p.Ala2195del)	LRRK2	A2195del	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001051669	12	40748106 - 40748108	12	40354304 - 40354306	1051669	1047926		NC_000012.12:40354303:TGCTG:TG
NM_198578.4(LRRK2):c.1721del (p.Pro574fs)	LRRK2	P574fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000930781	12	40668448	12	40274646	930781	919428		NC_000012.12:40274645:CC:C
NM_198578.4(LRRK2):c.1289-6del	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000664397	12	40651044	12	40257242	664397	652698	rs758855054	NC_000012.12:40257241:T:
NM_198578.4(LRRK2):c.4037del (p.Gly1346fs)	LRRK2	G1346fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000632191	12	40702345	12	40308543	632191	620442	rs1565737297	NC_000012.12:40308542:GG:G
NM_198578.4(LRRK2):c.2701_2702delinsCT (p.Ser901Leu)	LRRK2	S901L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000465215	12	40687358 - 40687359	12	40293556 - 40293557	465215	462432	rs1555184069	NC_000012.12:40293555:TC:CT
NM_198578.4(LRRK2):c.*936del	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308666	12	40762493	12	40368691	308666	324748	rs367772598	NC_000012.12:40368690:TTTTTTTTTTT:TTTTTTTTTT
NM_198578.4(LRRK2):c.*131del	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308652	12	40761697	12	40367895	308652	317028	rs572544182	NC_000012.12:40367894:TT:T
NM_198578.4(LRRK2):c.4317+12del	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000308633	12	40703047	12	40309245	308633	324696	rs200829235	NC_000012.12:40309244:T:
NM_198578.4(LRRK2):c.3497-8del	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000308626	12	40696576	12	40302774	308626	332341	rs201739149	NC_000012.12:40302773:TTTTTTTT:TTTTTTT
NM_198578.4(LRRK2):c.7468del (p.Gln2490fs)	LRRK2	Q2490fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039242	12	40761451	12	40367649	39242	47848	rs281865058	NC_000012.12:40367648:C:
NM_198578.4(LRRK2):c.6187_6191del (p.Leu2062_Leu2063insTer)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039220	12	40740629 - 40740633	12	40346827 - 40346831	39220	47826	rs111739194	NC_000012.12:40346826:CTACTCTA:CTA
NM_198578.4(LRRK2):c.4364_4365del (p.Asp1455fs)	LRRK2	D1455fs	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039188	12	40704279 - 40704280	12	40310477 - 40310478	39188	47794	rs281865049	NC_000012.12:40310476:AT:
NM_001127392.3(MYRF):c.2358_2359del (p.Tyr787fs)	MYRF	Y778fs, Y787fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000985076	11	61547714 - 61547715	11	61780242 - 61780243	985076	973799		NC_000011.10:61780241:TGT:T
NM_006186.4(NR4A2):c.*659_*661del	NR4A2		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331652	2	157181595 - 157181597	2	156325083 - 156325085	331652	282312	rs577936871	NC_000002.12:156325082:TTATT:TT
NR4A2, 1-BP DEL, -291T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000007679					7679	22718		
NM_007262.5(PARK7):c.471_473del (p.Pro158del)	PARK7	P158del	not provided|Young-onset Parkinson disease|Parkinson disease 7	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000987356	1	8045015 - 8045017	1	7984955 - 7984957	987356	974988		NC_000001.11:7984954:GCC:
NC_000001.11:g.(?_7969325)_(7969424_?)del	PARK7		Parkinson disease 7	Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000584372	1	8029385 - 8029484	1	7969325 - 7969424	584372	556503		
nsv513788	PARK7		Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007063	1	8018845 - 8044954			7063	22102		
NC_000001.10:g.(?_20972043)_(20972226_?)del	PINK1		Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001074575	1	20972043 - 20972226			1074575	1056845		
NM_032409.3(PINK1):c.273del (p.Cys92fs)	PINK1	C92fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000664114	1	20960314	1	20633821	664114	627314	rs755000580	NC_000001.11:20633820:C:
NM_032409.3(PINK1):c.322del (p.Leu108fs)	PINK1	L108fs	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000631589	1	20960363	1	20633870	631589	619985	rs1557559393	NC_000001.11:20633869:C:
NM_032409.3(PINK1):c.599del (p.Ala200fs)	PINK1	A200fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000581272	1	20964546	1	20638053	581272	556768	rs1557561340	NC_000001.11:20638052:C:
NM_032409.3(PINK1):c.*571del	PINK1|PINK1-AS		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295025	1	20977754	1	20651261	295025	278549	rs556390159	NC_000001.11:20651260:CC:C
NM_032409.3(PINK1):c.*356_*357del	PINK1|PINK1-AS		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295017	1	20977539 - 20977540	1	20651046 - 20651047	295017	279814	rs886045849	NC_000001.11:20651045:GCG:G
NM_032409.3(PINK1):c.620del (p.Arg207fs)	PINK1	R207fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	VCV000189240	1	20964567	1	20638074	189240	187107	rs756677845	NC_000001.11:20638073:G:
NM_005216.4(DDOST):c.*807_*5409del	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 14, 2005)	no assertion criteria provided	VCV000002412	1	20973463 - 20978065	1	20646970 - 20651572	2412	17451		
NM_016203.4(PRKAG2):c.*896del	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359329	7	151253391	7	151556305	359329	310209	rs532079387	NC_000007.14:151556304:AAAAA:AAAA
NM_016203.4(PRKAG2):c.*1021del	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359326	7	151253266	7	151556180	359326	310322	rs11329945	NC_000007.14:151556179:AAAAAAAAAA:AAAAAAAAA
NM_016203.4(PRKAG2):c.*1021_*1022delinsGT	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359325	7	151253265 - 151253266	7	151556179 - 151556180	359325	302210	rs886062094	NC_000007.14:151556178:CA:AC
NM_016203.4(PRKAG2):c.*1040del	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359323	7	151253247	7	151556161	359323	305395	rs56898021	NC_000007.14:151556160:AAAAAAAAAAA:AAAAAAAAAA
GRCh37/hg19 6q26(chr6:161969922-161990424)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120009	6	161807890 - 162206818			1120009	1108779		
GRCh37/hg19 6q26(chr6:162206818-162206900)	PRKN		Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120008	6	161990424 - 162394320			1120008	1108780		
GRCh37/hg19 6q26(chr6:162394320-162475157)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120006	6	162206900 - 162622150			1120006	1108781		
GRCh37/hg19 6q26(chr6:162864400-162864441)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120005	6	162683772 - 163146228			1120005	1108784		
GRCh37/hg19 6q26(chr6:162475128-162475157)	PRKN		Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120003	6	162394382 - 162622150			1120003	1108782		
GRCh37/hg19 6q26(chr6:162622150-162622256)	PRKN		Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120002	6	162475157 - 162683576			1120002	1108783		
NC_000006.11:g.(?_162475113)_(162864519_?)del	PRKN		not provided	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001073296	6	162475113 - 162864519			1073296	1057203		
GRCh37/hg19 6q26(chr6:162137107-162137163)	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000976673	6	162137107 - 162137163			976673	964910		
NM_004562.3(PRKN):c.337_376del (p.Pro113fs)	PRKN	P113fs	not provided|Young-onset Parkinson disease	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000846957	6	162683593 - 162683632	6	162262561 - 162262600	846957	831746		NC_000006.12:162262560:CAGTGTGCAGAATGACAGCCAGCCCCACAGAGTCTCCTGG:
NC_000006.12:g.(?_162201121)_(162201262_?)del	PRKN		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000831103	6	162622153 - 162622294			831103	819677		
NM_004562.3(PRKN):c.101del (p.Gln34fs)	PRKN	Q34fs	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000810636	6	162864412	6	162443380	810636	798915		NC_000006.12:162443379:T:
NC_000006.12:g.(?_161569335)_(161569436_?)del	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000583674	6	161990367 - 161990468	6	161569335 - 161569436	583674	560399		
Single allele	PRKN		Parkinson disease 2	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000560128	6	162621943 - 162941426	6	162200911 - 162520394	560128	550844		
NC_000006.12:g.(?_161785752)_(161973437_?)del	PRKN		not provided|Parkinson disease 2	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000536459	6	162206784 - 162394469	6	161785752 - 161973437	536459	521887		
NM_004562.3(PRKN):c.155del (p.Asn52fs)	PRKN	N52fs	Parkinson disease 2|Young-onset Parkinson disease|not provided	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000536457	6	162864358	6	162443326	536457	521494	rs754809877	NC_000006.12:162443325:TT:T
NC_000006.12:g.(?_162262505)_(162443493_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000468581			6	162262505 - 162443493	468581	455116		
NC_000006.12:g.(?_162262505)_(162262785_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000468580			6	162262505 - 162262785	468580	455271		
NC_000006.12:g.(?_162201111)_(162262785_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000468579	6	162622143 - 162683817	6	162201111 - 162262785	468579	455998		
NC_000006.12:g.(?_162201111)_(162201272_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000468578			6	162201111 - 162201272	468578	455265		
NM_004562.3(PRKN):c.101_102del (p.Gln34fs)	PRKN	Q34fs	not provided|Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000425403	6	162864411 - 162864412	6	162443379 - 162443380	425403	413737	rs55777503	NC_000006.12:162443378:CT:
NC_000006.12:g.(?_162054091)_(162054174_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000417464	6	162475123 - 162475206	6	162054091 - 162054174	417464	395171		
NC_000006.12:g.(?_162201131)_(162443473_?)del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000417459	6	162622163 - 162864505	6	162201131 - 162443473	417459	395641		
NM_004562.3(PRKN):c.*887_*890del	PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356004	6	161770241 - 161770244	6	161349209 - 161349212	356004	306800	rs572345942	NC_000006.12:161349208:TATCTAT:TAT
PARK2, EX5-6DEL	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000007055					7055	22094		
PARK2, 1-BP DEL, 1072T	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007052					7052	22091		
PARK2, 1-BP DEL, 255A	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000007048					7048	22087		
NM_004562.2(PRKN):c.735-?_871+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007045	6	162206804 - 162206940	6	161785772 - 161785908	7045	22084		
PARK2, 1-BP DEL, 202A	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 22, 2003)	no assertion criteria provided	VCV000007044					7044	22083		
NM_004562.2(PRKN):c.872-?_1083+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Oct 24, 1998)	no assertion criteria provided	VCV000007041	6	161969886 - 161990448	6	161548854 - 161569416	7041	22080		
NM_004562.2(PRKN):c.8-?_171+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000007040	6	162864342 - 162864505	6	162443310 - 162443473	7040	22079		
NM_004562.2(PRKN):c.413-?_534+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000007035	6	162622163 - 162622284	6	162201131 - 162201252	7035	22074		
NM_004562.2(PRKN):c.172-?_871+?del	PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Apr 9, 1998)	no assertion criteria provided	VCV000007034	6	162206804 - 162683797	6	161785772 - 162262765	7034	22073		
PSEN1, 3-BP DEL	PSEN1		Alzheimer disease, familial, 3, with spastic paraparesis and unusual plaques	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000018154					18154	33193		
PTH, IVS2DS, G-C, +1, EX2DEL	PTH		Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000013757					13757	28796		
NM_014363.6(SACS):c.9956_9957del (p.Lys3319fs)	SACS	K3319fs, K3172fs	not provided	Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000817415	13	23908058 - 23908059	13	23333919 - 23333920	817415	805768	rs772704931	NC_000013.11:23333918:TTT:T
NM_001080517.3(SETD5):c.648del (p.Gln216fs)	SETD5	Q118fs, Q216fs	Intellectual disability	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV000978944	3	9482220	3	9440536	978944	966943		NC_000003.12:9440535:G:
NM_000543.5(SMPD1):c.996del (p.Phe333fs)	SMPD1	F332fs, F333fs, P12fs	Niemann-Pick disease, type A|Niemann-Pick disease, type B|not provided|Niemann-Pick disease, type B|Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002990	11	6413286	11	6392056	2990	18029	rs387906289	NC_000011.10:6392055:CCCCCC:CCCCC
NM_000345.4(SNCA):c.*1077del	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350089	4	90646702	4	89725551	350089	299963	rs886059724	NC_000004.12:89725550:A:
NM_000345.4(SNCA):c.*1245del	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350087	4	90646534	4	89725383	350087	294645	rs886059722	NC_000004.12:89725382:AAAAAAAAAAA:AAAAAAAAAA
NM_000345.4(SNCA):c.*1311del	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350071	4	90646468	4	89725317	350071	296153	rs886059717	NC_000004.12:89725316:G:
NM_203446.3(SYNJ1):c.125-6_125-5del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001165211	21	34074362 - 34074363	21	32702052 - 32702053	1165211	1158960		NC_000021.9:32702051:AAAAAAAA:AAAAAA
NM_203446.3(SYNJ1):c.-56_-55delinsAT	SYNJ1	C21Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001016364	21	34100289 - 34100290	21	32727978 - 32727979	1016364	1014313		NC_000021.9:32727977:GC:AT
NM_203446.3(SYNJ1):c.*276del	SYNJ1	F1349fs, F1435fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001009392	21	34003839	21	32631529	1009392	999141		NC_000021.9:32631528:AAA:AA
NM_203446.3(SYNJ1):c.2254del (p.Asp752fs)	SYNJ1	D747fs, D752fs, D791fs	Parkinson disease 20, early-onset	Likely pathogenic	criteria provided, single submitter	VCV000992917	21	34037273	21	32664963	992917	980855		NC_000021.9:32664962:CCC:CC
NM_203446.3(SYNJ1):c.3457del (p.Gly1152_Val1153insTer)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000950404	21	34015741	21	32643431	950404	929292		NC_000021.9:32643430:CCCC:CCC
NM_203446.3(SYNJ1):c.3126del (p.Ser1043fs)	SYNJ1	S1043fs, S1082fs, S1038fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000848199	21	34018824	21	32646514	848199	848689		NC_000021.9:32646513:GGGGG:GGGG
NM_203446.3(SYNJ1):c.*576_*584del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000836370	21	34003531 - 34003539	21	32631221 - 32631229	836370	848674		NC_000021.9:32631220:GCTGACTTTG:G
NC_000021.9:g.(?_32727926)_(32728060_?)del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000833242	21	34100237 - 34100371			833242	821362		
NM_203446.3(SYNJ1):c.706-7del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000793252	21	34066628	21	32694318	793252	788255	rs202044634	NC_000021.9:32694317:AAAAAAAAA:AAAAAAAA
NM_203446.3(SYNJ1):c.2541_2542delinsTT (p.His848Tyr)	SYNJ1	H848Y, H887Y, H843Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000760171	21	34029350 - 34029351	21	32657040 - 32657041	760171	773286	rs1601309236	NC_000021.9:32657039:GC:AA
NM_203446.3(SYNJ1):c.949-31_949-2del	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000754385	21	34058229 - 34058258	21	32685919 - 32685948	754385	776715	rs1281313151	NC_000021.9:32685918:TGAAAGTAAAAAGGCAAATATTCATCTAAATGAAAGTAAAAAGGCAAATAT:TGAAAGTAAAAAGGCAAATAT
NM_203446.3(SYNJ1):c.789+8_789+11del	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000725945	21	34066527 - 34066530	21	32694217 - 32694220	725945	745133	rs751922511	NC_000021.9:32694216:CAAACA:CA
NM_203446.3(SYNJ1):c.*677_*679del	SYNJ1	F1569del, F1483del	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000708218	21	34003436 - 34003438	21	32631126 - 32631128	708218	728858	rs528030561	NC_000021.9:32631125:AGAAG:AG
NM_203446.3(SYNJ1):c.3281_3286del (p.Leu1094_Pro1095del)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 2, 2018)	criteria provided, single submitter	VCV000579422	21	34018061 - 34018066	21	32645751 - 32645756	579422	573038	rs1283379982	NC_000021.9:32645750:GCGGCAGCGGC:GCGGC
NM_203446.3(SYNJ1):c.*316del	SYNJ1	T1363fs, T1449fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000571107	21	34003799	21	32631489	571107	571475	rs1569014970	NC_000021.9:32631488:T:
NM_203446.3(SYNJ1):c.2793_2797del (p.Arg932fs)	SYNJ1	R971fs, R927fs, R932fs	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000570902	21	34028997 - 34029001	21	32656687 - 32656691	570902	571490	rs778394516	NC_000021.9:32656686:CTTAT:
NM_203446.3(SYNJ1):c.-67_-56del	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000544571	21	34100290 - 34100301	21	32727979 - 32727990	544571	533795	rs1035093736	NC_000021.9:32727978:CAGCCGCCGCCACAGCCGCCG:CAGCCGCCG
NM_203446.3(SYNJ1):c.1933_1934delinsAG (p.Gln645Arg)	SYNJ1	Q645R, Q640R, Q684R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000478332	21	34038761 - 34038762	21	32666451 - 32666452	478332	471120	rs1555896707	NC_000021.9:32666450:TG:CT
NM_001077653.2(TBX20):c.995del (p.Pro332fs)	TBX20	P332fs	Hypoplastic left heart syndrome|Hypoplastic right heart syndrome|Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000438266	7	35244090	7	35204478	438266	431889	rs1554284604	NC_000007.14:35204477:GGGG:GGG
Single allele	TNFRSF9|PARK7		Parkinson Disease, Juvenile	Pathogenic(Last reviewed: May 12, 2021)	no assertion criteria provided	VCV001098717	1	7995073 - 8031023			1098717	1087426		
NM_000363.5(TNNI3):c.12-7del	TNNI3		Familial restrictive cardiomyopathy|not specified|Familial hypertrophic cardiomyopathy 1|Cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000043361	19	55668683	19	55157315	43361	52531	rs370714315	NC_000019.10:55157314:GG:G
NM_004181.5(UCHL1):c.326-4del	UCHL1		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000348771	4	41263719	4	41261702	348771	293417	rs3214812	NC_000004.12:41261701:TTTTTTTTTT:TTTTTTTTT
NM_007126.5(VCP):c.446-4_446-3delinsAT	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000842949	9	35065381 - 35065382	9	35065384 - 35065385	842949	851337		NC_000009.12:35065383:GC:AT
NM_020821.3(VPS13C):c.4777del (p.Gln1593fs)	VPS13C	Q1550fs, Q1593fs	Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222071	15	62239491	15	61947292	222071	223767	rs869312811	NC_000015.10:61947291:GGG:GG
NM_018206.6(VPS35):c.915-3del	VPS35		not provided|Parkinson disease 17	Benign(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV000703789	16	46708575	16	46674663	703789	695697	rs569369937	NC_000016.10:46674662:AAAAAAAAAAAAAA:AAAAAAAAAAAAA
NM_018206.6(VPS35):c.*258del	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319288	16	46694126	16	46660214	319288	341504	rs886052012	NC_000016.10:46660213:C:
NM_018206.6(VPS35):c.*281delinsAAAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319280	16	46694103	16	46660191	319280	325355	rs1555522775	NC_000016.10:46660190:G:TTTTT
NM_018206.6(VPS35):c.*281delinsAAAA	VPS35		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319279	16	46694103	16	46660191	319279	342998	rs1555522775	NC_000016.10:46660190:G:TTTT
NM_018206.6(VPS35):c.*283del	VPS35		not provided|Parkinson Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 2, 2019)	criteria provided, conflicting interpretations	VCV000319278	16	46694101	16	46660189	319278	325357	rs886052005	NC_000016.10:46660188:G:
